Outcome of influenza vaccination in combat-related post-traumatic stress disorder (PTSD) patients.
Identifieur interne : 000804 ( PubMed/Corpus ); précédent : 000803; suivant : 000805Outcome of influenza vaccination in combat-related post-traumatic stress disorder (PTSD) patients.
Auteurs : E. Kosor Krnic ; A. Gagro ; D. Kozaric-Kovacic ; M. Vilibic ; M. Grubisic-Ilic ; V. Folnegovic-Smalc ; V. Drazenovic ; E. Cecuk-Jelicic ; I. Gjenero-Margan ; I. Kuzman ; T. Jeren ; A. Sabioncello ; V. Kerhin-Brkljacic ; B. Kaic ; A. Markotic ; K. Gotovac ; S. Rabatic ; G. Mlinaric-Galinovic ; D. DekarisSource :
- Clinical and experimental immunology [ 0009-9104 ] ; 2007.
English descriptors
- KwdEn :
- Adult, Antibodies, Viral (biosynthesis), Antibodies, Viral (blood), CD8-Positive T-Lymphocytes (immunology), Female, HLA-A Antigens (analysis), HLA-A2 Antigen, Humans, Immunity, Cellular, Influenza A virus (immunology), Influenza B virus (immunology), Influenza Vaccines (immunology), Male, Middle Aged, Stress Disorders, Post-Traumatic (immunology), T-Lymphocytes, Cytotoxic (immunology), Vaccination, Veterans.
- MESH :
- chemical , analysis : HLA-A Antigens.
- chemical , biosynthesis : Antibodies, Viral.
- chemical , blood : Antibodies, Viral.
- immunology : CD8-Positive T-Lymphocytes, Influenza A virus, Influenza B virus, Influenza Vaccines, Stress Disorders, Post-Traumatic, T-Lymphocytes, Cytotoxic.
- Adult, Female, HLA-A2 Antigen, Humans, Immunity, Cellular, Male, Middle Aged, Vaccination, Veterans.
Abstract
Post-traumatic stress disorder (PTSD) is an anxiety disorder that can occur after exposure to extreme traumatic experience such as war trauma, and is accompanied by fear, helplessness or horror. Exposure to trauma can result in immune dysregulation and influence susceptibility to infectious disease as well as vaccine efficacy. The aim of the study was to determine the relation of psychological stress and the immune response to influenza vaccination in combat-related PTSD patients (n = 28). Detection of anti-viral antibody titre was performed by inhibition of haemagglutination assay. Ex vivo tetramer staining of CD8(+) T lymphocytes was used to monitor T cells specific for human leucocyte antigen (HLA)-A*0201-restricted influenza A haemagglutinin antigens before and after vaccination. Twenty patients showed a fourfold antibody titre increase to one or both influenza A viral strains, and 18 of them showed the same response for both influenza B viral strains. Ten of 15 healthy controls showed a fourfold rise in antibody titre to both influenza A viral strains and eight of them showed the same response for both influenza B viral strains. HLA-A*0201(+) PTSD patients (n = 10) showed a significant increase of influenza-specific CD8 T cells after vaccination. Although those PTSD patients had a lower number of influenza-specific CD8(+) T cells before vaccination compared to HLA-A*0201(+) healthy controls (n = 6), there was no difference in influenza A antibody titre between PTSD patients and control subjects before vaccination. The generated humoral and cellular immune response in PTSD patients argues against the hypothesis that combat-related PTSD in war veterans might affect protection following influenza vaccination.
DOI: 10.1111/j.1365-2249.2007.03410.x
PubMed: 17511777
Links to Exploration step
pubmed:17511777Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Outcome of influenza vaccination in combat-related post-traumatic stress disorder (PTSD) patients.</title>
<author><name sortKey="Kosor Krnic, E" sort="Kosor Krnic, E" uniqKey="Kosor Krnic E" first="E" last="Kosor Krnic">E. Kosor Krnic</name>
<affiliation><nlm:affiliation>Institute of Immunology, Department of Research and Development, Cellular Immunology Unit, Dubrava University Hospital, Zagreb, Croatia. ekosor@imz.hr</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gagro, A" sort="Gagro, A" uniqKey="Gagro A" first="A" last="Gagro">A. Gagro</name>
</author>
<author><name sortKey="Kozaric Kovacic, D" sort="Kozaric Kovacic, D" uniqKey="Kozaric Kovacic D" first="D" last="Kozaric-Kovacic">D. Kozaric-Kovacic</name>
</author>
<author><name sortKey="Vilibic, M" sort="Vilibic, M" uniqKey="Vilibic M" first="M" last="Vilibic">M. Vilibic</name>
</author>
<author><name sortKey="Grubisic Ilic, M" sort="Grubisic Ilic, M" uniqKey="Grubisic Ilic M" first="M" last="Grubisic-Ilic">M. Grubisic-Ilic</name>
</author>
<author><name sortKey="Folnegovic Smalc, V" sort="Folnegovic Smalc, V" uniqKey="Folnegovic Smalc V" first="V" last="Folnegovic-Smalc">V. Folnegovic-Smalc</name>
</author>
<author><name sortKey="Drazenovic, V" sort="Drazenovic, V" uniqKey="Drazenovic V" first="V" last="Drazenovic">V. Drazenovic</name>
</author>
<author><name sortKey="Cecuk Jelicic, E" sort="Cecuk Jelicic, E" uniqKey="Cecuk Jelicic E" first="E" last="Cecuk-Jelicic">E. Cecuk-Jelicic</name>
</author>
<author><name sortKey="Gjenero Margan, I" sort="Gjenero Margan, I" uniqKey="Gjenero Margan I" first="I" last="Gjenero-Margan">I. Gjenero-Margan</name>
</author>
<author><name sortKey="Kuzman, I" sort="Kuzman, I" uniqKey="Kuzman I" first="I" last="Kuzman">I. Kuzman</name>
</author>
<author><name sortKey="Jeren, T" sort="Jeren, T" uniqKey="Jeren T" first="T" last="Jeren">T. Jeren</name>
</author>
<author><name sortKey="Sabioncello, A" sort="Sabioncello, A" uniqKey="Sabioncello A" first="A" last="Sabioncello">A. Sabioncello</name>
</author>
<author><name sortKey="Kerhin Brkljacic, V" sort="Kerhin Brkljacic, V" uniqKey="Kerhin Brkljacic V" first="V" last="Kerhin-Brkljacic">V. Kerhin-Brkljacic</name>
</author>
<author><name sortKey="Kaic, B" sort="Kaic, B" uniqKey="Kaic B" first="B" last="Kaic">B. Kaic</name>
</author>
<author><name sortKey="Markotic, A" sort="Markotic, A" uniqKey="Markotic A" first="A" last="Markotic">A. Markotic</name>
</author>
<author><name sortKey="Gotovac, K" sort="Gotovac, K" uniqKey="Gotovac K" first="K" last="Gotovac">K. Gotovac</name>
</author>
<author><name sortKey="Rabatic, S" sort="Rabatic, S" uniqKey="Rabatic S" first="S" last="Rabatic">S. Rabatic</name>
</author>
<author><name sortKey="Mlinaric Galinovic, G" sort="Mlinaric Galinovic, G" uniqKey="Mlinaric Galinovic G" first="G" last="Mlinaric-Galinovic">G. Mlinaric-Galinovic</name>
</author>
<author><name sortKey="Dekaris, D" sort="Dekaris, D" uniqKey="Dekaris D" first="D" last="Dekaris">D. Dekaris</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17511777</idno>
<idno type="pmid">17511777</idno>
<idno type="doi">10.1111/j.1365-2249.2007.03410.x</idno>
<idno type="wicri:Area/PubMed/Corpus">000804</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000804</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Outcome of influenza vaccination in combat-related post-traumatic stress disorder (PTSD) patients.</title>
<author><name sortKey="Kosor Krnic, E" sort="Kosor Krnic, E" uniqKey="Kosor Krnic E" first="E" last="Kosor Krnic">E. Kosor Krnic</name>
<affiliation><nlm:affiliation>Institute of Immunology, Department of Research and Development, Cellular Immunology Unit, Dubrava University Hospital, Zagreb, Croatia. ekosor@imz.hr</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gagro, A" sort="Gagro, A" uniqKey="Gagro A" first="A" last="Gagro">A. Gagro</name>
</author>
<author><name sortKey="Kozaric Kovacic, D" sort="Kozaric Kovacic, D" uniqKey="Kozaric Kovacic D" first="D" last="Kozaric-Kovacic">D. Kozaric-Kovacic</name>
</author>
<author><name sortKey="Vilibic, M" sort="Vilibic, M" uniqKey="Vilibic M" first="M" last="Vilibic">M. Vilibic</name>
</author>
<author><name sortKey="Grubisic Ilic, M" sort="Grubisic Ilic, M" uniqKey="Grubisic Ilic M" first="M" last="Grubisic-Ilic">M. Grubisic-Ilic</name>
</author>
<author><name sortKey="Folnegovic Smalc, V" sort="Folnegovic Smalc, V" uniqKey="Folnegovic Smalc V" first="V" last="Folnegovic-Smalc">V. Folnegovic-Smalc</name>
</author>
<author><name sortKey="Drazenovic, V" sort="Drazenovic, V" uniqKey="Drazenovic V" first="V" last="Drazenovic">V. Drazenovic</name>
</author>
<author><name sortKey="Cecuk Jelicic, E" sort="Cecuk Jelicic, E" uniqKey="Cecuk Jelicic E" first="E" last="Cecuk-Jelicic">E. Cecuk-Jelicic</name>
</author>
<author><name sortKey="Gjenero Margan, I" sort="Gjenero Margan, I" uniqKey="Gjenero Margan I" first="I" last="Gjenero-Margan">I. Gjenero-Margan</name>
</author>
<author><name sortKey="Kuzman, I" sort="Kuzman, I" uniqKey="Kuzman I" first="I" last="Kuzman">I. Kuzman</name>
</author>
<author><name sortKey="Jeren, T" sort="Jeren, T" uniqKey="Jeren T" first="T" last="Jeren">T. Jeren</name>
</author>
<author><name sortKey="Sabioncello, A" sort="Sabioncello, A" uniqKey="Sabioncello A" first="A" last="Sabioncello">A. Sabioncello</name>
</author>
<author><name sortKey="Kerhin Brkljacic, V" sort="Kerhin Brkljacic, V" uniqKey="Kerhin Brkljacic V" first="V" last="Kerhin-Brkljacic">V. Kerhin-Brkljacic</name>
</author>
<author><name sortKey="Kaic, B" sort="Kaic, B" uniqKey="Kaic B" first="B" last="Kaic">B. Kaic</name>
</author>
<author><name sortKey="Markotic, A" sort="Markotic, A" uniqKey="Markotic A" first="A" last="Markotic">A. Markotic</name>
</author>
<author><name sortKey="Gotovac, K" sort="Gotovac, K" uniqKey="Gotovac K" first="K" last="Gotovac">K. Gotovac</name>
</author>
<author><name sortKey="Rabatic, S" sort="Rabatic, S" uniqKey="Rabatic S" first="S" last="Rabatic">S. Rabatic</name>
</author>
<author><name sortKey="Mlinaric Galinovic, G" sort="Mlinaric Galinovic, G" uniqKey="Mlinaric Galinovic G" first="G" last="Mlinaric-Galinovic">G. Mlinaric-Galinovic</name>
</author>
<author><name sortKey="Dekaris, D" sort="Dekaris, D" uniqKey="Dekaris D" first="D" last="Dekaris">D. Dekaris</name>
</author>
</analytic>
<series><title level="j">Clinical and experimental immunology</title>
<idno type="ISSN">0009-9104</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antibodies, Viral (biosynthesis)</term>
<term>Antibodies, Viral (blood)</term>
<term>CD8-Positive T-Lymphocytes (immunology)</term>
<term>Female</term>
<term>HLA-A Antigens (analysis)</term>
<term>HLA-A2 Antigen</term>
<term>Humans</term>
<term>Immunity, Cellular</term>
<term>Influenza A virus (immunology)</term>
<term>Influenza B virus (immunology)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Stress Disorders, Post-Traumatic (immunology)</term>
<term>T-Lymphocytes, Cytotoxic (immunology)</term>
<term>Vaccination</term>
<term>Veterans</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>HLA-A Antigens</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>CD8-Positive T-Lymphocytes</term>
<term>Influenza A virus</term>
<term>Influenza B virus</term>
<term>Influenza Vaccines</term>
<term>Stress Disorders, Post-Traumatic</term>
<term>T-Lymphocytes, Cytotoxic</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Female</term>
<term>HLA-A2 Antigen</term>
<term>Humans</term>
<term>Immunity, Cellular</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Vaccination</term>
<term>Veterans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Post-traumatic stress disorder (PTSD) is an anxiety disorder that can occur after exposure to extreme traumatic experience such as war trauma, and is accompanied by fear, helplessness or horror. Exposure to trauma can result in immune dysregulation and influence susceptibility to infectious disease as well as vaccine efficacy. The aim of the study was to determine the relation of psychological stress and the immune response to influenza vaccination in combat-related PTSD patients (n = 28). Detection of anti-viral antibody titre was performed by inhibition of haemagglutination assay. Ex vivo tetramer staining of CD8(+) T lymphocytes was used to monitor T cells specific for human leucocyte antigen (HLA)-A*0201-restricted influenza A haemagglutinin antigens before and after vaccination. Twenty patients showed a fourfold antibody titre increase to one or both influenza A viral strains, and 18 of them showed the same response for both influenza B viral strains. Ten of 15 healthy controls showed a fourfold rise in antibody titre to both influenza A viral strains and eight of them showed the same response for both influenza B viral strains. HLA-A*0201(+) PTSD patients (n = 10) showed a significant increase of influenza-specific CD8 T cells after vaccination. Although those PTSD patients had a lower number of influenza-specific CD8(+) T cells before vaccination compared to HLA-A*0201(+) healthy controls (n = 6), there was no difference in influenza A antibody titre between PTSD patients and control subjects before vaccination. The generated humoral and cellular immune response in PTSD patients argues against the hypothesis that combat-related PTSD in war veterans might affect protection following influenza vaccination.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17511777</PMID>
<DateCompleted><Year>2007</Year>
<Month>09</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0009-9104</ISSN>
<JournalIssue CitedMedium="Print"><Volume>149</Volume>
<Issue>2</Issue>
<PubDate><Year>2007</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Clinical and experimental immunology</Title>
<ISOAbbreviation>Clin. Exp. Immunol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Outcome of influenza vaccination in combat-related post-traumatic stress disorder (PTSD) patients.</ArticleTitle>
<Pagination><MedlinePgn>303-10</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Post-traumatic stress disorder (PTSD) is an anxiety disorder that can occur after exposure to extreme traumatic experience such as war trauma, and is accompanied by fear, helplessness or horror. Exposure to trauma can result in immune dysregulation and influence susceptibility to infectious disease as well as vaccine efficacy. The aim of the study was to determine the relation of psychological stress and the immune response to influenza vaccination in combat-related PTSD patients (n = 28). Detection of anti-viral antibody titre was performed by inhibition of haemagglutination assay. Ex vivo tetramer staining of CD8(+) T lymphocytes was used to monitor T cells specific for human leucocyte antigen (HLA)-A*0201-restricted influenza A haemagglutinin antigens before and after vaccination. Twenty patients showed a fourfold antibody titre increase to one or both influenza A viral strains, and 18 of them showed the same response for both influenza B viral strains. Ten of 15 healthy controls showed a fourfold rise in antibody titre to both influenza A viral strains and eight of them showed the same response for both influenza B viral strains. HLA-A*0201(+) PTSD patients (n = 10) showed a significant increase of influenza-specific CD8 T cells after vaccination. Although those PTSD patients had a lower number of influenza-specific CD8(+) T cells before vaccination compared to HLA-A*0201(+) healthy controls (n = 6), there was no difference in influenza A antibody titre between PTSD patients and control subjects before vaccination. The generated humoral and cellular immune response in PTSD patients argues against the hypothesis that combat-related PTSD in war veterans might affect protection following influenza vaccination.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kosor Krnic</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Institute of Immunology, Department of Research and Development, Cellular Immunology Unit, Dubrava University Hospital, Zagreb, Croatia. ekosor@imz.hr</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gagro</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kozaric-Kovacic</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Vilibic</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Grubisic-Ilic</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Folnegovic-Smalc</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y"><LastName>Drazenovic</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y"><LastName>Cecuk-Jelicic</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gjenero-Margan</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kuzman</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y"><LastName>Jeren</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sabioncello</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kerhin-Brkljacic</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kaic</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y"><LastName>Markotic</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gotovac</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rabatic</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mlinaric-Galinovic</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Dekaris</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2007</Year>
<Month>05</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Clin Exp Immunol</MedlineTA>
<NlmUniqueID>0057202</NlmUniqueID>
<ISSNLinking>0009-9104</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015234">HLA-A Antigens</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C435939">HLA-A*02:01 antigen</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015789">HLA-A2 Antigen</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015234" MajorTopicYN="N">HLA-A Antigens</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015789" MajorTopicYN="N">HLA-A2 Antigen</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007111" MajorTopicYN="N">Immunity, Cellular</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009981" MajorTopicYN="N">Influenza B virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013313" MajorTopicYN="N">Stress Disorders, Post-Traumatic</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013602" MajorTopicYN="N">T-Lymphocytes, Cytotoxic</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014728" MajorTopicYN="N">Veterans</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year>
<Month>5</Month>
<Day>22</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2007</Year>
<Month>9</Month>
<Day>19</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2007</Year>
<Month>5</Month>
<Day>22</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">17511777</ArticleId>
<ArticleId IdType="pii">CEI3410</ArticleId>
<ArticleId IdType="doi">10.1111/j.1365-2249.2007.03410.x</ArticleId>
<ArticleId IdType="pmc">PMC1941948</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Eur J Immunogenet. 2000 Feb;27(1):47-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10651851</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brain Behav Immun. 2005 Jul;19(4):325-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15944072</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychosom Med. 2000 Jul-Aug;62(4):502-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10949095</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychosom Med. 2000 Nov-Dec;62(6):804-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11139000</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Psychiatry. 2001 Mar;158(3):484-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11229994</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Depress Anxiety. 2001;13(3):132-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11387733</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Environ Health Perspect. 2001 Aug;109(8):757-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11564609</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2002 Jan;76(2):582-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11752149</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Depress Anxiety. 2002;16(1):14-38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12203669</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Exp Immunol. 2003 Feb;131(2):335-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12562397</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2003 May 1;21(16):1801-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12686098</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Psychiatry. 2003 Sep;160(9):1705-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12944352</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Psychosom Res. 2003 Dec;55(6):569-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14642989</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2004 Mar 15;172(6):3437-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15004143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychol Bull. 2004 Jul;130(4):601-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15250815</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br Med Bull. 1979 Jan;35(1):69-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">367490</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 1981;7(2):135-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7264612</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 1981 Oct 24;2(8252):887-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6117682</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1987 May 1;138(9):3010-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3571981</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 1991 Aug 29;325(9):606-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1713648</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 1993 Aug 4;270(5):595-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8331758</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Psychiatry. 1995 Apr;152(4):516-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7900929</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3043-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8610165</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 1996 Aug;14(12):1108-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8911005</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Trauma Stress. 1998 Jan;11(1):87-101</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9479678</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Psychol. 1998 May;17(3):214-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9619470</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann N Y Acad Sci. 1998 May 1;840:649-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9629291</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1998 Nov;72(11):8682-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9765409</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Bone Marrow Transplant. 1998 Dec;22 Suppl 4:S27-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9916628</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 1999 Feb 20;353(9153):627-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10030328</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mil Med. 2005 Mar;170(3):223-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15828699</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Immunol. 2000 May;61(5):438-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10773346</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000804 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000804 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= StressCovidV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:17511777 |texte= Outcome of influenza vaccination in combat-related post-traumatic stress disorder (PTSD) patients. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:17511777" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a StressCovidV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |